ArticleIn vivo (Athens, Greece)

Pre-treatment Tumor Size and Tumor Growth Rate as Prognostic Predictors for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Nivolumab.

Yuri Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.